Supplemental information (Tables)

3 Months Ended

Nov. 30, 2020

Supplemental Cash Flow Elements [Abstract]

Schedule of Depreciation and Amortization Expense

The Company has recorded the following depreciation and amortization expense in the Consolidated Condensed Statements of Earnings (in millions):

	Three months ended November 30,
	2020		2019
Depreciation expense	$	360	$	359
Intangible asset and other amortization	115		118
Total depreciation and amortization expense	$	475	$	477

Restrictions on Cash and Cash Equivalents

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of November 30, 2020 and August 31, 2020 (in millions):

	November 30, 2020		August 31, 2020
Cash and cash equivalents	$	1,111	$	516
Restricted cash (included in other current assets)	228		230
Cash, cash equivalents and restricted cash	$	1,339	$	746

Schedule of Cash and Cash Equivalents

The following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of November 30, 2020 and August 31, 2020 (in millions):

	November 30, 2020		August 31, 2020
Cash and cash equivalents	$	1,111	$	516
Restricted cash (included in other current assets)	228		230
Cash, cash equivalents and restricted cash	$	1,339	$	746

Schedule of Dividends Payable

Cash dividends per common share declared were as follows:

Quarter ended	2020		2019
November	$	0.4675	$	0.4575